α-Ketoglutarate Attenuates Hyperlipidemia-Induced Endothelial Damage by Activating the Erk-Nrf2 Signaling Pathway to Inhibit Oxidative Stress and Mitochondrial Dysfunction
Antioxidants & Redox Signaling · 2023-10 · 39 (10-12) · 777-793
DOI: 10.1089/ars.2022.0215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 16.10.2023. Verfasst von Danyu Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Center for Mitochondrial Biology and Medicine, School of Life Scie…. Hauptthemen laut MEDLINE: Oxidative Stress, Hyperlipidemias, NF-E2-Related Factor 2, Mitochondria. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Aims: α-Ketoglutarate (AKG) is an intermediate of the tricarboxylic acid cycle and a key hub linking amino acid metabolism and glucose oxidation. Previous studies have shown that AKG improved cardiovascular diseases such as myocardial infarction and myocardial hypertrophy through antioxidant and lipid-lowering characteristics. However, its protective effect and mechanism on endothelial injury caused by hyperlipidemia have not been elucidated yet. In this study, we tested whether AKG possesses protective effects on hyperlipidemia-induced endothelial injury and studied the mechanism.
Results
AKG administration both in vivo , and in vitro significantly suppressed the hyperlipidemia-induced endothelial damage, regulated ET-1 and nitric oxide levels, and reduced the inflammatory factor interleukin-6 and matrix metallopeptidase-1 by inhibiting oxidative stress and mitochondrial dysfunction. The protective effects were achieved by the mechanism of activating the Nrf2 phase II system through the ERK signaling pathway. Innovation: These results reveal the role of the AKG-ERK-Nrf2 signaling pathway in the prevention of hyperlipidemia-induced endothelial damage, and suggest that AKG, as a mitochondria-targeting nutrient, is a potential drug for the treatment of endothelial damage in hyperlipidemia.
Conclusion
AKG ameliorated the hyperlipidemia-induced endothelial damage and inflammatory response by inhibiting oxidative stress and mitochondrial dysfunction. Antioxid. Redox Signal . 39, 777–793. Color images are available online.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Center for Mitochondrial Biology and Medicine, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China.
- School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao, China.
ORCID-Profile: Danyu Cheng, Jiankang Liu
Zitieren
APA
Cheng, D., Liu, X., Gao, Y., Cui, L., Wang, M., Zheng, Y., Lv, W., Zhao, L., & Liu, J. (2023). α-Ketoglutarate Attenuates Hyperlipidemia-Induced Endothelial Damage by Activating the Erk-Nrf2 Signaling Pathway to Inhibit Oxidative Stress and Mitochondrial Dysfunction. Antioxidants & Redox Signaling, 39(10-12), 777-793. https://doi.org/10.1089/ars.2022.0215
Vancouver
Cheng D, Liu X, Gao Y, Cui L, Wang M, Zheng Y, et al. α-Ketoglutarate Attenuates Hyperlipidemia-Induced Endothelial Damage by Activating the Erk-Nrf2 Signaling Pathway to Inhibit Oxidative Stress and Mitochondrial Dysfunction. Antioxidants & Redox Signaling. 2023;39(10-12):777-793. doi:10.1089/ars.2022.0215
BibTeX
@article{Cheng2023,
author = {Cheng, Danyu and Liu, Xuyun and Gao, Yilin and Cui, Li and Wang, Min and Zheng, Yezi and Lv, Weiqiang and Zhao, Lin and Liu, Jiankang},
title = {α-Ketoglutarate Attenuates Hyperlipidemia-Induced Endothelial Damage by Activating the Erk-Nrf2 Signaling Pathway to Inhibit Oxidative Stress and Mitochondrial Dysfunction},
journal = {Antioxidants & Redox Signaling},
year = {2023},
volume = {39},
number = {10-12},
pages = {777--793},
doi = {10.1089/ars.2022.0215}
}
EUVIMED